A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy

Theranostics

Volumn 5, Issue 9, 2015, Pages 946-960

  Liu, Yang ^a,b   Ashton, Jeffrey R ^a   Moding, Everett J ^c   Yuan, Hsiangkuo ^a   Register, Janna K ^a   Fales, Andrew M ^a   Choi, Jaeyeon ^c   Whitley, Melodi J ^c   Zhao, Xiaoguang ^c   Qi, Yi ^c   Ma, Yan ^c   Vaidyanathan, Ganesan ^c   Zalutsky, Michael R ^c   Kirsch, David G ^c   Badea, Cristian T ^c   Vo Dinh, Tuan ^a,b  

^a Duke University   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biodistribution; CT; Gold nanostars; Nanoparticles; Photothermal therapy; SERS; Theranostics; Tumor imaging

Indexed keywords

GOLD NANOPARTICLE; GOLD;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEATING; IMAGING; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LASER; MOUSE; NANOPROBE; NEAR INFRARED LASER; NONHUMAN; PARTICLE SIZE; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; RAMAN SPECTROMETRY; SARCOMA; TWO PHOTON LUMINESCENCE IMAGING; ZETA POTENTIAL; ANIMAL; FLUORESCENCE IMAGING; HUMAN; PROCEDURES; THERANOSTIC NANOMEDICINE; THERMOTHERAPY; TREATMENT OUTCOME;

ANIMALS; GOLD; HUMANS; HYPERTHERMIA, INDUCED; MICE; MODELS, ANIMAL; OPTICAL IMAGING; SARCOMA; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME;

EID: 84945965822     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.11974     Document Type: Article

References (74)

1. Cheng Y, Morshed RA, Auffinger B, Tobias AL, Lesniak MS. Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Delivery Rev. 2014; 66: 42-57.
2. Wang LN, Wang YB, Li ZJ. Nanoparticle-based tumor theranostics with molecular imaging. Curr Pharm Biotechno. 2013; 14: 683-92.
3. Kim CS, Duncan B, Creran B, Rotello VM. Triggered nanoparticles as therapeutics. Nano Today. 2013; 8: 439-47.
4. Sun XL, Huang XL, Yan XF, Wang Y, Guo JX, Jacobson O, et al. Chelator-free Cu-64-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy. ACS Nano. 2014; 8: 8438-46.
5. Zhao L, Kim TH, Ahn JC, Kim HW, Kim SY. Highly efficient "theranostics" system based on surface-modified gold nanocarriers for imaging and photodynamic therapy of cancer. J Mater Chem B. 2013; 1: 5806-17.
6. Mieszawska AJ, Mulder WJM, Fayad ZA, Cormode DP. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharmaceut. 2013; 10: 831-47.
7. Gad SC, Sharp KL, Montgomery C, Payne JD, Goodrich GP. Evaluation of the toxicity of intravenous delivery of Auroshell particles (Gold-silica nanoshells). Int J Toxicol. 2012; 31: 584-94.
8. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001; 19: 316-7.
9. Pekkanen AM, DeWitt MR, Rylander MN. Nanoparticle enhanced optical imaging and phototherapy of cancer. J Biomed Nanotechnol. 2014; 10: 1677-712.
10. Bayazitoglu Y, Kheradmand S, Tullius TK. An overview of nanoparticle assisted laser therapy. Int J Heat Mass Tran. 2013; 67: 469-86.
11. Schlucker S. Surface-enhanced Raman spectroscopy: Concepts and chemical applications. Angew Chem Int Ed Engl. 2014; 53: 4756-95.
12. Yuan HK, Liu Y, Fales AM, Li YL, Liu J, Vo-Dinh T. Quantitative surface-enhanced resonant Raman scattering multiplexing of biocompatible gold nanostars for in vitro and ex vivo detection. Anal Chem. 2013; 85: 208-12.
13. Yuan H, Wilson CM, Xia J, Doyle SL, Li S, Fales AM, et al. Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor. Nanoscale. 2014; 6: 4078-82.
14. Yuan H, Register JK, Wang HN, Fales AM, Liu Y, Vo-Dinh T. Plasmonic nanoprobes for intracellular sensing and imaging. Anal Bioanal Chem. 2013; 405: 6165-80.
15. Vo-Dinh T, Fales AM, Griffin GD, Khoury CG, Liu Y, Ngo H, et al. Plasmonic nanoprobes: From chemical sensing to medical diagnostics and therapy. Nanoscale. 2013; 5: 10127-40.
16. Liu Y, Yuan H, Vo-Dinh T. Spectroscopic and vibrational analysis of the methoxypsoralen system: A comparative experimental and theoretical study. J Mol Struct. 2013; 1035: 13-8.
17. Liu Y, Sun H. Electronic ground states and vibrational frequency shifts of diatomic ligands in heme adducts. J Comput Chem. 2011; 32: 1279-85.
18. Vo-Dinh T. Surface-enhanced Raman spectroscopy using metallic nanostructures. TrAC, Trends Anal Chem. 1998; 17: 557-82.
19. Zhao J, Liu Y, Fales AM, Register JK, Yuan H, Vo-Dinh T. Direct analysis of traditional Chinese medicines using surface-enhanced Raman scattering (SERS). Drug Test Anal. 2014; 6: 1063-8.
20. Nie SM, Emery SR. Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science. 1997; 275: 1102-6.
21. Kumar D, Saini N, Jain N, Sareen R, Pandit V. Gold nanoparticles: an era in bionanotechnology. Expert Opin Drug Deliv. 2013; 10: 397-409.
22. Xie J, Lee S, Chen XY. Nanoparticle-based theranostic agents. Adv Drug Delivery Rev. 2010; 62: 1064-79.
23. Cai QY, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol. 2007; 42: 797-806.
24. Liu Y, Yuan H, Kersey F, Register J, Parrott M, Vo-Dinh T. Plasmonic gold nanostars for multi-modality sensing and diagnostics. Sensors. 2015; 15: 3706-20.
25. Scaffidi JP, Gregas MK, Seewaldt V, Vo-Dinh T. SERS-based plasmonic nanobiosensing in single living cells. Anal Bioanal Chem. 2009; 393: 1135-41.
26. Alak AM, Vo-Dinh T. Silver-coated fumed silica as a substrate material for surface-enhanced Raman scattering. Anal Chem. 1989; 61: 656-60.
27. Vo-Dinh T, Meier M, Wokaun A. Surface-enhanced Raman-spectrometry with silver particles on stochastic-post substrates. Anal Chim Acta. 1986; 181: 139-48.
28. Vo-Dinh T, Hiromoto MYK, Begun GM, Moody RL. Surface-enhanced Raman spectrometry for trace organic analysis. Anal Chem. 1984; 56: 1667-70.
29. Yuan H, Khoury CG, Hwang H, Wilson CM, Grant GA, Tuan V-D. Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging. Nanotechnology. 2012; 23: 075102.
30. Yuan H, Khoury CG, Wilson CM, Grant GA, Bennett AJ, Vo-Dinh T. In vivo particle tracking and photothermal ablation using plasmon-resonant gold nanostars. Nanomedicine: NBM. 2012; 8: 1355-63.
31. Yuan HK, Fales AM, Khoury CG, Liu J, Vo-Dinh T. Spectral characterization and intracellular detection of surface-enhanced Raman scattering (SERS)-encoded plasmonic gold nanostars. J Raman Spectrosc. 2013; 44: 234-9.
32. Liu Y, Chang Z, Yuan H, Fales AM, Vo-Dinh T. Quintuple-modality (SERS-MRI-CT-TPL-PTT) plasmonic nanoprobe for theranostics. Nanoscale. 2013; 5: 12126-31.
33. Mito JK, Min HD, Ma Y, Carter JE, Brigman BE, Dodd L, et al. Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. J Pathol. 2013; 229: 132-40.
34. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med. 2007; 13: 992-7.
35. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001; 15: 3243-8.
36. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet. 2001; 29: 418-25.
37. Badea CT, Johnston S, Johnson B, Lin M, Hedlund LW, Johnson GA. A dual micro-CT system for small animal imaging. Proc SPIE. 2008; 6913: 691342.
38. Clark D, Ghaghada K, Moding E, Kirsch D, Badea C. In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT. Phys Med Biol. 2013; 58: 1683-704.
39. Ashton JR, Clark DP, Moding EJ, Ghaghada K, Kirsch DG, West JL, et al. Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study. PLoS One. 2014; 9: e88129.
40. Ayala-Orozco C, Urban C, Knight MW, Urban AS, Neumann O, Bishnoi SW, et al. Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshells. ACS Nano. 2014; 8: 6372-81.
41. Roper DK, Ahn W, Hoepfner M. Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles. J Phys Chem C. 2007; 111: 3636-41.
42. Kim YH, Jeon J, Hong SH, Rhim WK, Lee YS, Youn H, et al. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small. 2011; 7: 2052-60.
43. Black KCL, Wang YC, Luehmann HP, Cai X, Xing WX, Pang B, et al. Radioactive Au-198-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano. 2014; 8: 4385-94.
44. Singh M, Lima A, Molina R, Hamilton P, Clermont AC, Devasthali V, et al. Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. Nat Biotechnol. 2010; 28: 585-93.
45. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009; 324: 1457-61.
46. Chen Z, Cheng K, Walton Z, Wang Y, Ebi H, Shimamura T, et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature. 2012; 483: 613-7.
47. Liu Y, Yuan H, Fales AM, Vo-Dinh T. pH-sensing nanostar probe using surface-enhanced Raman scattering (SERS): Theoretical and experimental studies. J Raman Spectrosc. 2013; 44: 980-6.
48. Liu Y, Yuan HK, Fales AM, Vo-Dinh T. Plasmonic gold nanostar for biomedical sensing. Proc SPIE. 2014; 8957: 5.
49. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004; 209: 171-6.
50. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A. 2003; 100: 13549-54.
51. Ko AH, Dollinger M, Rosenbaum EH. Everyone's guide to cancer therapy: How cancer is diagnosed, treated, and managed day to day. Kansas City, USA: Andrews McMeel Publishing; 2008.
52. Meier M, Wokaun A, Vo-Dinh T. Silver particles on stochastic quartz substrates providing tenfold increase in Raman enhancement. J Phys Chem. 1985; 89: 1843-6.
53. Enlow PD, Buncick M, Warmack RJ, Vo-Dinh T. Detection of nitro polynuclear aromatic-compounds by surface-enhanced Raman-spectrometry. Anal Chem. 1986; 58: 1119-23.
54. Bello JM, Stokes DL, Vo-Dinh T. Titanium-dioxide based substrate for optical monitors in surface-enhanced Raman-scattering analysis. Anal Chem. 1989; 61: 1779-83.
55. Alak AM, Vo-Dinh T. Surface-enhanced Raman-spectrometry of organophosphorus chemical-agents. Anal Chem. 1987; 59: 2149-53.
56. Karabeber H, Huang R, Iacono P, Samii JM, Pitter K, Holland EC, et al. Guiding brain tumor resection using surface-enhanced Raman scattering nanoparticles and a hand-held Raman scanner. ACS Nano. 2014.
57. Cole JR, Mirin NA, Knight MW, Goodrich GP, Halas NJ. Photothermal efficiencies of nanoshells and nanorods for clinical therapeutic applications. J Phys Chem C. 2009; 113: 12090-4.
58. Ngwa W, Kumar R, Sridhar S, Korideck H, Zygmanski P, Cormack RA, et al. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine. 2014; 9: 1063-82.
59. Gao N, Chen Y, Li L, Guan Z, Zhao T, Zhou N, et al. Shape-dependent two-photon photoluminescence of single gold nanoparticles. J Phys Chem C. 2014; 118: 13904-11.
60. Bentzen SM, Gregoire V. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol. 2011; 21: 101-10.
61. Sykes EA, Chen J, Zheng G, Chan WCW. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano. 2014; 8: 5696-706.
62. Doane T, Burda C. Nanoparticle mediated non-covalent drug delivery. Adv Drug Delivery Rev. 2013; 65: 607-21.
63. Chen CC, Wu CJ, Yeh MK. Gold nanoparticle-based platforms as cancer-targeted molecules delivery systems. Int J Nanotechnol. 2013; 10: 840-9.
64. Beech JR, Shin SJ, Smith JA, Kelly KA. Mechanisms for targeted delivery of nanoparticles in cancer. Curr Pharm Design. 2013; 19: 6560-74.
65. Toy R, Peiris PM, Ghaghada KB, Karathanasis E. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine. 2014; 9: 121-34.
66. Black KCL, Wang Y, Luehmann HP, Cai X, Xing W, Pang B, et al. Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano. 2014; 8: 4385-94.
67. Perez-Campana C, Gomez-Vallejo V, Puigivila M, Martin A, Calvo-Fernandez T, Moya SE, et al. Biodistribution of different sized nanoparticles assessed by positron emission tomography: A general strategy for direct activation of metal oxide particles. ACS Nano. 2013; 7: 3498-505.
68. Ding YP, Li SP, Nie GJ. Nanotechnological strategies for therapeutic targeting of tumor vasculature. Nanomedicine. 2013; 8: 1209-22.
69. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010; 7: 653-64.
70. Li D, Johanson G, Emond C, Carlander U, Philbert M, Jolliet O. Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats. Nanotoxicology. 2014; 8 Suppl 1: 128-37.
71. Zhang L, Chen H, Wang L, Liu T, Yeh J, Lu G, et al. Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy. Nanotechnology, science and applications. 2010; 3: 159-70.
72. McLaughlin MF, Woodward J, Boll RA, Wall JS, Rondinone AJ, Kennel SJ, et al. Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy. Plos One. 2013; 8: e54531.
73. Agarwal A, Shao X, Rajian JR, Zhang HA, Chamberland DL, Kotov NA, et al. Dual-mode imaging with radiolabeled gold nanorods. J Biomed Opt. 2011; 16: 051307.
74. Xing Y, Zhao JH, Conti PS, Chen K. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 2014; 4: 290-306.